Answers are grounded in this paper and cite their sources.
Castration-resistant prostate cancer (CRPC) is a common male malignancy that requires new therapeutic strategies due to acquired resistance to its first-line treatment, docetaxel. The benefits of vitamin D on prostate cancer (PCa) progression have been previously reported. This study aimed to investigate the effects of vitamin D on chemoresistance in CRPC.
No takes yet. Share an insight, caveat, or question.
Len‐Tayon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: